FP
Fredun Pharma Stock: price and insider trades · India
Fredun Pharma: what insiders have been doing
Only a handful of insider records exist for Fredun Pharma, the last one from 15 May 2026, too few to describe a trend. This summary is built from SEBI (PIT + SAST) disclosures alone and does not predict where the share price will go.
Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Fundamental score
Ranked 18,208 of 26,897 companies
39.9
score / 100
Value27
Quality53
FCF yld-2.5%
Earn yld1.3%
EV/EBITDA29.0x
ROE16%
Gross mgn27%
Net mgn5.2%
Debt/EBITDA2.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
₹1,430.05
Analyst consensus
Income statement
Revenue₹6.3B
Gross profit₹1.7B27% margin
EBITDA₹927.3M15% margin
Net income₹326.2M5.2% margin
Valuation
PER (trailing)51.9x
P/Book8.4x
Beta0.86
Balance sheet & cash
Market cap₹24.4B
Total debt₹2.4B
Free Cash Flow-₹616.9M
Debt / Equity87%
Profitability & ownership
ROE15.6%
ROA9.1%
% insiders54.5%
% institutions0.0%
Last declaration on 15 May 2026
Declarations1 total
- 40,000 shares-Conv. of WarrantsSEBI:d4039c2bc46cf44ed12bebbcd90b4e2f43908a88
1 of 1 declaration
About Fredun Pharma
Fredun Pharma is a company specialized in the health and pharmaceutical sector. It is listed on the XBOM market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
